Roche, Genentech Acquire Unlimited Access to Open Monoclonal Technology's OmniRat®

By: Benzinga
Open Monoclonal Technology, Inc. (OMT), an innovator in transgenic research for discovery of human therapeutic antibodies, today announced that Genentech, a member of the Roche Group, and Roche (OTC: RHHBY ) will acquire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.